Xi'an Mokemei Biotechnology: difference between revisions
Diff·revision 31 → 32·22:08, 9 Aug 2025
Difference between revision 31 and revision 32 of Xi'an Mokemei Biotechnology. 3 lines changed; the page grew by 367 bytes.
| Revision 31 — 11:26, 4 Aug 2025 PrimarySrcPatia (talk) copyedit 7,580 bytes +27 | Revision 32 — 22:08, 9 Aug 2025 TallySheetTad (talk) add confidence interval 7,947 bytes +367 | ||
|---|---|---|---|
| 55 | A discrepancy of that size between an independent report and a certificate has several innocent explanations — different columns, different integration parameters, different [[Reference standard|reference standards]], sample handling between purchase and testing — and does not establish that either figure was wrong. It is recorded because [[Purity claim inflation|inflated purity claims]] are a documented failure mode in this sector and a discrepancy is the only observable that would indicate one.{{r|reports}} | 55 | A discrepancy of that size between an independent report and a certificate has several innocent explanations — different columns, different integration parameters, different [[Reference standard|reference standards]], sample handling between purchase and testing — and does not establish that either figure was wrong. It is recorded because [[Purity claim inflation|inflated purity claims]] are a documented failure mode in this sector and a discrepancy is the only observable that would indicate one.{{r|reports}} |
| 56 | 56 | ||
| + | 57 | == Reception == | |
| + | 58 | The PeptidePedia tally records 776 self-reported submissions to July 2026 — below the median for the supplier articles. Recurring complaints concern certificate consistency and the lot-matching discrepancies noted above; recurring positive themes are price and catalogue breadth.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | |
| + | 59 | ||
| 57 | == References == | 60 | == References == |
| 58 | {{reflist}} | 61 | {{reflist}} |